SCHEMBL15044985

SCHEMBL15044985

C[C@@H]1CCN(C2CCN(C(=O)OC(C)(C)C)CC2)C1=O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 2/20 0.54
TP53 P04637 1/20 0.52
GPR119 Q8TDV5 4/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.47
HPGD P15428 1/20 0.47
RECQL P46063 1/20 0.45
EPHX1 P07099 1/20 0.45
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
PTPN6 P29350 1/20 0.44
KMT2A Q03164 1/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CTSD P07339 1/20 0.42
CTSE P14091 1/20 0.42
BACE1 P56817 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15022876 0.86 FPR2 (0.54) FPR2TP53GPR119KDM4EMAPT
SCHEMBL789114 0.86 FPR2 (0.54) FPR2TP53GPR119KDM4EMAPT
SCHEMBL23336156 0.86 FPR2 (0.54) FPR2TP53GPR119KDM4EMAPT
SCHEMBL13779816 0.84 FPR2 (0.53) FPR2TP53GPR119KDM4EMAPT
SCHEMBL15107831 0.84 FPR2 (0.53) FPR2TP53GPR119KDM4EMAPT
SCHEMBL789786 0.84 FPR2 (0.55) FPR2TP53GPR119KDM4EMAPT
SCHEMBL20986882 0.84 FPR2 (0.57) FPR2TP53GPR119KDM4EMAPT
SCHEMBL20986885 0.84 FPR2 (0.57) FPR2TP53GPR119KDM4EMAPT
SCHEMBL20986883 0.84 FPR2 (0.57) FPR2TP53GPR119KDM4EMAPT
SCHEMBL22720490 0.83 FPR2 (0.52) FPR2TP53GPR119KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2014-09-11 US disclosed
US-8754226-B2 Piperidinyl-substituted lactams as GPR119 modulators ARRAY BIOPHARMA INC. (US) 2014-06-17 US disclosed
US-20130184257-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2013-07-18 US disclosed
US-20130158009-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256756-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GLP1R FPR2 142/4885TP53 4810/4885GPR119 1/4885
US-20130158009-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GPR39 FPR2 328/4885TP53 4790/4885GPR119 1/4885
US-20130184257-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GPR180 FPR2 192/4885TP53 4756/4885GPR119 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.